Anti-TNFRSF5/CD40 Antibody (Ravagalimab)
Catalog No.
F1064
Anti-TNFRSF5/CD40 Antibody (Ravagalimab)
Featured Products
Ravagalimab (ABBV-323) is a CD40 antagonist (EC50: 3.7 nM). Ravagalimab can be used in the research of Crohn's disease.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.04 kDa
Dry ice
2050816-56-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
PR-1629977, ABBV-323
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P25942
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFRSF5 / CD40
Please avoid freeze-thaw cycles.